NYU School of Medicine, Neurogenetics Division — New York, New York

NYU School of Medicine, Neurogenetics Division is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

NYU School of Medicine, Neurogenetics Division has participated in 1 clinical trials.

Therapeutic areas: Mucopolysaccharidosis II, MPS II.

Sponsors: Sangamo Therapeutics.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU School of Medicine, Neurogenetics Division?

NYU School of Medicine, Neurogenetics Division has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU School of Medicine, Neurogenetics Division conducted?

NYU School of Medicine, Neurogenetics Division has 1 clinical trials on record. Their work covers Mucopolysaccharidosis II, MPS II.

Is NYU School of Medicine, Neurogenetics Division accredited by Crixeo Health?

NYU School of Medicine, Neurogenetics Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU School of Medicine, Neurogenetics Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.